Real-World Treatment Patterns for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in Europe and the United States

被引：0
作者：
Rita Caldeira
Mark Scazafave
机构：
[1] Ipsos Healthcare,
[2] Ipsos Healthcare,undefined
来源：
Oncology and Therapy | 2016年 / 4卷 / 2期
关键词：
Chemotherapy; Endocrine therapy; Guidelines; Hormone receptor-positive breast cancer; Quality of care; Treatment patterns;
D O I：
10.1007/s40487-016-0033-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：189 / 197
页数：8
相关论文
共 16 条
[1]  
Cardoso F(2014)ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) Ann Oncol 25 1871-1888
[2]  
Costa A(2013)The development of endocrine therapy for women with breast cancer Cancer Treat Rev 39 507-517
[3]  
Norton L(2014)Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2−) breast cancer patients in the United States: 2002–2012 Curr Med Res Opin 30 1537-1545
[4]  
Sainsbury R(2014)Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer Curr Med Res Opin 30 1007-1016
[5]  
Swallow E(2015)Treatment patterns and duration in post-menopausal women with HR+/HER2− metastatic breast cancer in the US: a retrospective chart review in community oncology practices (2004–2010) Curr Med Res Opin 31 263-273
[6]  
Zhang J(undefined)undefined undefined undefined undefined-undefined
[7]  
Thomason D(undefined)undefined undefined undefined undefined-undefined
[8]  
Tan RD(undefined)undefined undefined undefined undefined-undefined
[9]  
Kageleiry A(undefined)undefined undefined undefined undefined-undefined
[10]  
Signorovitch J(undefined)undefined undefined undefined undefined-undefined
12